Jan. 5 (Bloomberg) –
, after months of concern
about his health and weight loss, said he is suffering from a
nutritional ailment and that he plans to remain
’s
chief executive officer during his treatment.
“I have been losing weight throughout 2008. The reason has
been a mystery to me and my doctors,” Jobs, who turns 54 in
February, said today in a statement. “After further testing, my
doctors think they have found the cause — a hormone Read the rest of this entry »

Six years after landmark research uncovered breast cancer risk in the nation’s most popular menopause treatment, two new Stanford University analyses show that using hormone replacement therapy long-term poses a far greater risk of cancer than previously thought.
The research concludes that a woman who stays on the therapy for at least five years doubles her risk of breast cancer every year. This 200 percent elevated risk is much greater than the Read the rest of this entry »

THURSDAY, Jan. 8 (HealthDay News) — Hormone therapy may lower a woman’s risk of colorectal cancer, especially if she is no longer taking the hormones.
This new finding, published in the January issue of
Cancer Epidemiology, Biomarkers and Prevention
, further complicates an already murky picture of the risks and benefits of hormone replacement therapy (HRT).
Previous landmark research has shown an increased risk of breast cancer and cardiovascular Read the rest of this entry »

HUNTINGTON — At least 22 federal lawsuits were filed over a period of two days against drug company Wyeth in which plaintiffs alleged the company’s hormone replacement therapy drugs for menopausal women can cause severe side effects such as cancer and cardiovascular disease.
In the complaints, the plaintiffs say they face an increased risk of heart attacks, blood clots, cardiovascular disease and breast cancer after taking Wyeth’s Prempro. They Read the rest of this entry »

This new finding, published in the January issue of
Cancer Epidemiology, Biomarkers and Prevention
, further complicates an already murky picture of the risks and benefits of hormone replacement therapy (HRT).
Previous landmark research has shown an increased risk of breast cancer and cardiovascular problems, but a lowered risk of colon cancer. More recent studies have found that the stage in life when a woman takes hormone therapy can influence Read the rest of this entry »

Taking hormones after menopause appears to accelerate loss of brain tissue in women over 64, which may explain why the therapy had previously been linked to an increased risk of dementia and mental decline in elderly women.
The brain-volume findings, published in today’s issue of Neurology, are the latest from the Women’s Health Initiative, a landmark government study of postmenopausal women. Over the last six years, it has firmly established that, Read the rest of this entry »

Cupertino (CA) – In a rather unusual move, Steve Jobs and Apple’s board of directors reacted to the rumors surrounding Jobs’ health. In an open letter to the Apple Community, Jobs stated that his weight loss in fact has been a concern and that doctors determined that a “hormone imbalance” is the “root cause” of the problem.
Apple and Steve Jobs the CEO decided to put an end to speculations and inform investors, fans and the  general public Read the rest of this entry »

Six years after landmark research uncovered breast cancer risk in the nation’s most popular menopause treatment, two new Stanford University analyses show that using long-term hormone replacement therapy poses a far greater risk of cancer than previously thought.
The research concludes that a woman who stays on the therapy for at least five years doubles her risk of breast cancer every year. This sharply elevated risk is much greater than the 27 Read the rest of this entry »

if they take hormone replacement therapy (called HRT for short). But not all studies show this.
. This means doctors don’t usually choose it first for treating osteoporosis.
).
). The studies compared HRT with other treatments or no treatment in women who had been through the menopause. The studies involved many thousands of women in all.
Two of the summaries showed that women who had gone through the menopause were less likely to break a Read the rest of this entry »

The number of breast cancer cases in the United States dropped markedly after women quit combination hormones for postmenopausal symptoms in droves in the early part of this decade, according to a paper published today in The New England Journal of Medicine.
Investigators also found that taking estrogen plus progestin for five years doubled a women’s chances of developing breast cancer — the most detailed indication yet that the cancer risks Read the rest of this entry »